Stocks›Healthcare›LNTH

LNTH

Lantheus Holdings, Inc.

NasdaqResearch view

Lantheus Holdings, Inc. operates in the In Vitro & In Vivo Diagnostic Substances industry.

$99.95−0.24%

Oct 6 close · 1D EOD · Databento

HealthcareIn Vitro & In Vivo Diagnostic SubstancesMid-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

1 story has a settled receipt so far (1 on the Wire). The record starts speaking at three.

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 6, 2024, before the open.

Last report

Aug 6, 2026−0.42%

before the open

Last 4, next close

median 3.02% either way

up 1 of 4

Every report since 2023 →Earnings calendar →

DateEventSourceNext close

Sep 22FDA approves Lantheus’ BRAVNETSA for neuroendocrine tumorsInvesting.comInvesting.com−0.28%
Aug 6Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗−0.42%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

32 big days in a year, and what we hold on each

A big day is a close more than 2.89% from the one before, three times LNTH’s median day (0.96%). On 12 of the 32, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±2.89%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayLNTHWhat we hold that dayGroup (median of 4) · each

1 Oct 8, 2025+3.30%
Before our storiesgroup +4.0%, moved with LNTH
1Oct 8, 2025+3.30%
Before our stories
+4.0% moved with LNTHNTLA +19.7 · NEOG +4.1 · CLDX +3.9 · IDXX +0.4
2 Oct 27, 2025+3.69%
Before our storiesgroup +0.7%, did not move with it
2Oct 27, 2025+3.69%
Before our stories
+0.7% did not move with itCLDX +2.4 · IDXX +1.0 · NEOG +0.3 · NTLA −42.2
3 Oct 31, 2025+3.96%
Before our storiesgroup +2.8%, moved with LNTH
3Oct 31, 2025+3.96%
Before our stories
+2.8% moved with LNTHNTLA +2.9 · NEOG +2.8 · CLDX +2.8 · IDXX +0.1
4 Nov 6, 2025−6.19%
Resultsgroup −2.8%, did not move with it
4Nov 6, 2025−6.19%
ResultsFirst close after the Nov 6 results filing
−2.8% did not move with itNTLA −9.2 · NEOG −3.7 · CLDX −2.0 · IDXX −0.9
5 Nov 7, 2025−4.88%
Before our storiesgroup −1.1%, did not move with it
5Nov 7, 2025−4.88%
Before our stories
−1.1% did not move with itNTLA −22.7 · CLDX −1.6 · IDXX −0.7 · NEOG +7.0
6 Nov 11, 2025+5.29%
Before our storiesgroup +3.6%, moved with LNTH
6Nov 11, 2025+5.29%
Before our stories
+3.6% moved with LNTHCLDX +7.5 · NTLA +4.6 · NEOG +2.7 · IDXX +0.4
7 Nov 21, 2025+4.16%
Before our storiesgroup +4.3%, moved with LNTH
7Nov 21, 2025+4.16%
Before our stories
+4.3% moved with LNTHNEOG +5.7 · IDXX +5.3 · CLDX +3.4 · NTLA +2.1
8 Nov 25, 2025+4.55%
Before our storiesgroup +2.2%, did not move with it
8Nov 25, 2025+4.55%
Before our stories
+2.2% did not move with itNTLA +2.4 · NEOG +2.4 · IDXX +1.9 · CLDX +0.5
9 Dec 4, 2025+3.51%
Before our storiesgroup +3.1%, moved with LNTH
9Dec 4, 2025+3.51%
Before our stories
+3.1% moved with LNTHNTLA +7.5 · CLDX +6.4 · NEOG −0.2 · IDXX −1.2
10 Dec 11, 2025+3.75%
Before our storiesgroup +0.8%, did not move with it
10Dec 11, 2025+3.75%
Before our stories
+0.8% did not move with itNTLA +1.9 · NEOG +0.9 · IDXX +0.8 · CLDX −0.9
11 Dec 12, 2025+5.58%
Before our storiesgroup −2.0%, did not move with it
11Dec 12, 2025+5.58%
Before our stories
−2.0% did not move with itIDXX −0.5 · CLDX −1.5 · NEOG −2.6 · NTLA −5.5
12 Dec 22, 2025+3.17%
Before our storiesgroup +2.7%, moved with LNTH
12Dec 22, 2025+3.17%
Before our stories
+2.7% moved with LNTHCLDX +6.5 · NTLA +5.1 · IDXX +0.3 · NEOG −1.0
13 Feb 10, 2026+3.01%
Before our storiesgroup +0.2%, did not move with it
13Feb 10, 2026+3.01%
Before our stories
+0.2% did not move with itNEOG +1.1 · IDXX +1.1 · CLDX −0.7 · NTLA −4.6
14 Mar 3, 2026+3.33%
Before our storiesgroup −2.9%, did not move with it
14Mar 3, 2026+3.33%
Before our stories
−2.9% did not move with itIDXX −0.2 · NEOG −2.2 · CLDX −3.5 · NTLA −11.9
15 Mar 6, 2026−4.91%
Before our storiesgroup −0.7%, did not move with it
15Mar 6, 2026−4.91%
Before our stories
−0.7% did not move with itNEOG −9.3 · IDXX −1.7 · CLDX +0.2 · NTLA +2.2
16 Mar 9, 2026+10.27%
Before our storiesgroup +1.8%, did not move with it
16Mar 9, 2026+10.27%
Before our stories
+1.8% did not move with itCLDX +4.4 · NTLA +3.4 · IDXX +0.3 · NEOG 0.0
17 Mar 10, 2026+4.01%
Before our storiesgroup −1.2%, did not move with it
17Mar 10, 2026+4.01%
Before our stories
−1.2% did not move with itCLDX +1.4 · NEOG −0.5 · IDXX −1.9 · NTLA −3.0
18 Mar 31, 2026+3.78%
Before our storiesgroup +5.9%, moved with LNTH
18Mar 31, 2026+3.78%
Before our stories
+5.9% moved with LNTHNTLA +10.0 · CLDX +7.6 · NEOG +4.3 · IDXX +0.9
19 Apr 30, 2026+4.25%
Before our storiesgroup +3.3%, moved with LNTH
19Apr 30, 2026+4.25%
Before our stories
+3.3% moved with LNTHNTLA +8.3 · NEOG +4.3 · CLDX +2.3 · IDXX +1.3
20 May 7, 2026+5.63%
Resultsgroup −1.1%, did not move with it
20May 7, 2026+5.63%
ResultsFirst close after the May 7 results filing
−1.1% did not move with itNEOG +0.8 · NTLA −1.0 · IDXX −1.2 · CLDX −3.1
21 May 20, 2026+3.44%
Before our storiesgroup +2.6%, moved with LNTH
21May 20, 2026+3.44%
Before our stories
+2.6% moved with LNTHNEOG +5.8 · NTLA +2.7 · CLDX +2.5 · IDXX +1.3
22 May 22, 2026+9.03%
Before our storiesgroup +0.8%, did not move with it
22May 22, 2026+9.03%
Before our stories
+0.8% did not move with itNTLA +1.9 · IDXX +1.1 · CLDX +0.5 · NEOG +0.5
23 Jun 3, 2026+4.10%
Before our storiesgroup +1.3%, did not move with it
23Jun 3, 2026+4.10%
Before our stories
+1.3% did not move with itCLDX +3.0 · IDXX +1.8 · NEOG +0.7 · NTLA −0.8
24 Jun 11, 2026+4.07%
Nothing on LNTHgroup +1.0%, did not move with it
24Jun 11, 2026+4.07%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
+1.0% did not move with itCLDX +2.1 · NTLA +1.2 · NEOG +0.8 · IDXX +0.2
25 Jun 25, 2026+3.97%
Nothing on LNTHgroup +2.2%, moved with LNTH
25Jun 25, 2026+3.97%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
+2.2% moved with LNTHNEOG +3.6 · NTLA +3.4 · IDXX +1.1 · CLDX +0.9
26 Jul 6, 2026−6.43%
Nothing on LNTHgroup +1.4%, did not move with it
26Jul 6, 2026−6.43%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
+1.4% did not move with itCLDX −1.1 · IDXX +1.3 · NTLA +1.6 · NEOG +1.8
27 Jul 8, 2026+3.23%
Nothing on LNTHgroup −2.5%, did not move with it
27Jul 8, 2026+3.23%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
−2.5% did not move with itNEOG −1.4 · CLDX −2.4 · IDXX −2.6 · NTLA −3.4
28 Jul 20, 2026−2.96%
Nothing on LNTHgroup −1.6%, moved with LNTH
28Jul 20, 2026−2.96%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
−1.6% moved with LNTHNTLA −4.0 · NEOG −2.5 · IDXX −0.6 · CLDX +0.2
29 Jul 21, 2026+3.40%
Nothing on LNTHgroup −0.1%, did not move with it
29Jul 21, 2026+3.40%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
−0.1% did not move with itNTLA +5.0 · CLDX +0.7 · NEOG −0.8 · IDXX −2.0
30 Jul 22, 2026−3.09%
Nothing on LNTHgroup −1.9%, moved with LNTH
30Jul 22, 2026−3.09%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
−1.9% moved with LNTHNTLA −3.0 · CLDX −2.5 · IDXX −1.4 · NEOG −1.0
31 Jul 27, 2026+3.06%
Nothing on LNTHgroup +0.2%, did not move with it
31Jul 27, 2026+3.06%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
+0.2% did not move with itIDXX +2.2 · CLDX +1.1 · NTLA −0.6 · NEOG −0.6
32 Jul 28, 2026−4.99%
Nothing on LNTHgroup +0.9%, did not move with it
32Jul 28, 2026−4.99%
Nothing on LNTHNo LNTH story, brief or results filing in our record that day
+0.9% did not move with itNEOG −1.6 · CLDX −0.2 · NTLA +2.1 · IDXX +2.4

A story on the same day is not a cause, and a group move is not proof either. Group: the median of IDXX, NEOG, CLDX and NTLA that day, the largest companies in LNTH’s SEC industry; “moved with LNTH” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). LNTH reports before the open, so day 1 is that day’s close. 3 of 4 times, day 6 ended on the same side as day 1.

Reported Nov 6, 2025

day 1−6.19%day 6−7.18%

Reported Feb 26, 2026

day 1−0.38%day 6+0.78%

Reported May 7, 2026

day 1+5.63%day 6+12.21%

Reported Aug 6, 2026

day 1−0.42%day 6−0.55%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 6 report: −1.29%. Four reports is a small sample.

Every report since 2023 →

Each line is LNTH’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$6.5B

Revenue$1.5B+0.50%

Net income$233.6M

EPS, diluted$3.41−21.80%

Gross margin61.1%

Operating margin20.2%

Return on equity21.4%

Debt / equity0.51

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$6.5B

Enterprise Value$6.7B

Income$233.6M

Sales$1.5B

Book/sh$16.70

Cash/sh$5.53

Dividend TTM—

Payout0%

Employees—

IPO—

Quick Ratio2.51

Current Ratio2.70

Debt/Eq0.51

EPS (ttm)$3.41

EPS this Y-21.8%

EPS past 3/5Y104.3%

Sales past 3/5Y18.1%

EPS Y/Y TTM-21.8%

Sales Y/Y TTM0.5%

Shs Outstand65.27M

ROA10.5%

ROE21.4%

ROIC18.0%

Gross Margin61.1%

Oper. Margin20.2%

Profit Margin15.2%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$425.2M

FY21

$935.1M

FY22

$1.3B

FY23

$1.5B

FY24

$1.5B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$425.2M	$935.1M	$1.3B	$1.5B	$1.5B
Gross Profit	$187.7M	$581.7M	$709.5M	$988.3M	$942.0M
Operating Income	$-60.8M	$36.2M	$364.6M	$457.0M	$310.8M
Net Income	$-71.3M	$28.1M	$326.7M	$312.4M	$233.6M
Diluted EPS	$-1.06	$0.40	$4.65	$4.36	$3.41
Operating Cash Flow	$53.9M	$281.8M	$305.3M	$544.8M	$390.1M
Free Cash Flow	—	—	—	—	—

Same industry

LNTH against four same-industry peers, a year at 100

LNTH is up 87.1% in a year. Neogen is up 2.2 times. Of these four, Celldex Therapeutics (+21.7%), Idexx Laboratories (−14.5%) and Intellia Therapeutics (−48.0%) did less. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 2.2-fold rise and a 48.0% fall both read honestly.

Share this chart

LNTH +87.1%. Neogen ×2.2, Celldex Therapeutics +21.7%, Idexx Laboratories −14.5%, Intellia Therapeutics −48.0%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in LNTH’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

IDXX$40.8B NEOG$2.6B CLDX$2.5B NTLA$1.7B QDEL$739M TKNO$483M MYGN$434M NNNN$242M

Follow the news. Track the move.

LNTH story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

Sector context/Market context

Sep 22

FDA approves Lantheus’ BRAVNETSA for neuroendocrine tumors

The FDA approved Lantheus’ BRAVNETSA for neuroendocrine tumors. The decision gives Lantheus a newly cleared oncology product, with commercial uptake and revenue contribution now the next measurable milestones.

Since story

-0.1%

2026-09-22 → 2026-10-06

Investing.com · 14d ago

View both sides →

Follow the news. Track the move.